| Accession | HRS899354 |
|---|---|
| BioSample Accession | SAMC2930729 |
| Individual accession | HRI684565 |
| Study accession | HRA005098 |
| Sample name | P22_2_BLDC |
| Sample title | P22_2_BLDC |
| Collection date | 2021-09-02 |
| Sample Type | Disease |
| Description | Tislelizumab plus cetuximab and irinotecan in patients with previously treated MSS and RAS wild-type advanced colorectal cancer |
| Tissue | blood cell |
| Release date | 2024-06-01 |